Item request has been placed!
×
Item request cannot be made.
×
Processing Request
New minor groove covering DNA binding mode of dinuclear Pt(II) complexes with various pyridine-linked bridging ligands and dual anticancer-antiangiogenic activities.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- المصدر:
Publisher: Springer Country of Publication: Germany NLM ID: 9616326 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1327 (Electronic) Linking ISSN: 09498257 NLM ISO Abbreviation: J Biol Inorg Chem Subsets: MEDLINE
- بيانات النشر:
Original Publication: Berlin : Springer, c1996-
- الموضوع:
- نبذة مختصرة :
New anticancer platinum(II) compounds simultaneously targeting tumor cells and tumor-derived neoangiogenesis, with new DNA interacting mode and large therapeutic window are appealing alternative to improve efficacy of clinical platinum chemotherapeutics. Herein, we describe three novel dinuclear [{Pt(en)Cl} 2 (μ-L)] 2+ complexes with different pyridine-like bridging ligands (L), 4,4'-bipyridine (Pt1), 1,2-bis(4-pyridyl)ethane (Pt2) and 1,2-bis(4-pyridyl)ethene (Pt3), which highly, positively charged aqua derivatives, [{Pt(en)(H 2 O)} 2 (μ-L)] 4+ , interact with the phosphate backbone forming DNA-Pt adducts with an unique and previously undescribed binding mode, called a minor groove covering. The results of this study suggested that the new binding mode of the aqua-Pt(II) complexes with DNA could be attributed to the higher anticancer activities of their chloride analogues. All three compounds, particularly complex [{Pt(en)Cl} 2 (μ-4,4'-bipy)]Cl 2 ·2H 2 O (4,4'-bipy is 4,4'-bipyridine) (Pt1), overcame cisplatin resistance in vivo in the zebrafish-mouse melanoma xenograft model, showed much higher therapeutic potential than antiangiogenic drug sunitinib malate, while effectively blocking tumor neovascularization and melanoma cell metastasis. Overall therapeutic profile showed new dinuclear Pt(II) complexes could be novel, effective and safe anticancer agents. Finally, the correlation with the structural characteristics of these complexes can serve as a useful tool for developing new and more effective anticancer drugs.
- References:
Onco Targets Ther. 2016 Sep 08;9:5495-505. (PMID: 27660467)
Proc Natl Acad Sci U S A. 1981 Apr;78(4):2179-83. (PMID: 6941276)
Angew Chem Int Ed Engl. 2015 May 26;54(22):6483-7. (PMID: 25873535)
Dalton Trans. 2016 Oct 4;45(39):15481-15491. (PMID: 27722449)
Biochim Biophys Acta. 2013 Sep;1832(9):1371-7. (PMID: 23357577)
Chem Commun (Camb). 2012 Apr 7;48(28):3388-90. (PMID: 22373586)
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3611-6. (PMID: 12655051)
J Comput Chem. 2009 Dec;30(16):2785-91. (PMID: 19399780)
Dalton Trans. 2013 Mar 7;42(9):3181-7. (PMID: 23165925)
Sci Rep. 2018 Jul 11;8(1):10448. (PMID: 29992995)
J Immunol Methods. 1989 May 12;119(2):203-10. (PMID: 2470825)
Molecules. 2014 Oct 27;19(11):17202-20. (PMID: 25350363)
Clin Cancer Res. 2000 Jul;6(7):2626-34. (PMID: 10914703)
J Med Chem. 2015 Feb 12;58(3):1442-51. (PMID: 25551180)
Biochemistry. 1987 Oct 6;26(20):6392-6. (PMID: 3427013)
J Phys Chem B. 2007 May 17;111(19):5047-52. (PMID: 17455977)
Dalton Trans. 2018 Apr 3;47(14):4902-4908. (PMID: 29546259)
J Clin Oncol. 2015 Dec 10;33(35):4219-26. (PMID: 26503202)
J Inorg Biochem. 2004 Oct;98(10):1578-84. (PMID: 15458819)
Chem Rev. 2016 Mar 9;116(5):3436-86. (PMID: 26865551)
Chem Sci. 2017 Jan 1;8(1):241-252. (PMID: 28451171)
J Med Chem. 2003 Mar 27;46(7):1210-9. (PMID: 12646031)
Dalton Trans. 2018 Oct 30;47(42):15091-15102. (PMID: 30303498)
Spectrochim Acta A Mol Biomol Spectrosc. 2008 Oct;70(5):1114-9. (PMID: 18061534)
J Inorg Biochem. 2001 Jan 1;83(1):49-55. (PMID: 11192699)
Curr Med Chem Anticancer Agents. 2005 May;5(3):267-79. (PMID: 15992354)
PLoS One. 2011;6(7):e21768. (PMID: 21765912)
Nucleic Acids Res. 2014 Dec 16;42(22):13474-87. (PMID: 25414347)
Phys Chem Chem Phys. 2019 Feb 20;21(8):4162-4175. (PMID: 30656331)
Inorg Chem. 2005 Dec 26;44(26):9598-600. (PMID: 16363817)
Chem Rev. 2019 Jan 23;119(2):1519-1624. (PMID: 30489072)
J Inorg Biochem. 2011 Mar;105(3):476-89. (PMID: 20926136)
Nat Rev Clin Oncol. 2019 Oct;16(10):601-620. (PMID: 31160735)
Nat Rev Drug Discov. 2015 Oct;14(10):721-31. (PMID: 26361349)
Biochemistry. 1992 Oct 6;31(39):9319-24. (PMID: 1390718)
Biochemistry. 1995 Nov 28;34(47):15480-6. (PMID: 7492537)
J Inorg Biochem. 2017 Sep;174:156-168. (PMID: 28675847)
J Inorg Biochem. 2016 Nov;164:5-16. (PMID: 27591123)
Dalton Trans. 2016 Aug 2;45(31):12444-57. (PMID: 27431616)
ChemMedChem. 2018 Sep 6;13(17):1755-1762. (PMID: 29932312)
Biochemistry. 2005 Apr 26;44(16):6059-70. (PMID: 15835895)
- Contributed Indexing:
Keywords: Dinuclear platinum(II) complexes; Dual anticancer and anti-angiogenic activity; Minor groove covering
- الرقم المعرف:
0 (Angiogenesis Inhibitors)
0 (Antineoplastic Agents)
0 (Ligands)
0 (Organoplatinum Compounds)
0 (Pyridines)
9007-49-2 (DNA)
91080-16-9 (calf thymus DNA)
NH9L3PP67S (pyridine)
- الموضوع:
Date Created: 20200313 Date Completed: 20210429 Latest Revision: 20210429
- الموضوع:
20221213
- الرقم المعرف:
10.1007/s00775-020-01770-7
- الرقم المعرف:
32162071
No Comments.